CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
GlaxoSmithKline SAE Company Snapshot
GlaxoSmithKline SAE operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline SAE with three other pharmaceutical manufacturers in Middle East: Hayat Pharmaceutical Industries Company PSC of JORDAN (2019 sales of 15.64 million Jordanian Dinars [US$22.06 million] ), Alexandria Pharmaceuticals and Chemical Industries Co (750.00 million Egyptian Pounds [US$46.89 million] ), and Dar Al Dawa Development and Investment Company PSC which is based in JORDAN (54.86 million Jordanian Dinars [US$77.38 million] of which 75% was Medicine).

Sales Analysis. During the year ended December of 2019, sales at GlaxoSmithKline SAE were 1.70 billion Egyptian Pounds (US$106.54 million). This is an increase of 5.0% versus 2018, when the company's sales were 1.62 billion Egyptian Pounds. This was the fourth straight year of sales growth at GlaxoSmithKline SAE. Sales of Consumer Care Sector saw an increase that was more than double the company's growth rate: sales were up 34.9% in 2019, from 242.13 million Egyptian Pounds to 326.53 million Egyptian Pounds. Not all segments of GlaxoSmithKline SAE experienced an increase in sales in 2019: sales of Medical Sector fell 0.3% to 1.38 billion Egyptian Pounds.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
GlaxoSmithKline SAE
  Stock Performance Chart for GlaxoSmithKline SAE
 
  Stock Data: Recent Stock Performance:
  Current Price (8/6/2020): 16.94
(Figures in Egyptian Pounds)
1 Week 0.1%   13 Weeks 0.9%  
4 Weeks 31.2%   52 Weeks n/a  
 
GlaxoSmithKline SAE Key Data:
  Ticker: BIOC Country: Egypt
  Exchanges: CAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 1,704,029,118
(Year Ending Jan 2020).
Employees: N/A
  Currency: Egyptian Pounds Market Cap: 1,414,730,548
  Fiscal Yr Ends: December Shares Outstanding: 83,514,200
  Share Type: Ordinary Closely Held Shares: 81,079,928
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.